Blood Pressure Lowering Trelagliptin Succinate Powder Pharmaceutical Trelagliptin Succinate Material Trelagliptin Succinate

Basic Info

Model NO.	D-Sung Syr-472
Powder	Yes
Customized	Customized
Certification	GMP, HSE, ISO 9001, USP, BP
Suitable for	Elderly
State	Powder
Purity	>99%
Product Name	Trelagliptin Succinate
Name	Trelagliptin Succinate Powder
Appearance	White Powder
Color	White
Grade	Pharmaceutical Grade
Assay	HPLC 99%
Application	Pharmaceutical Grade
Specific	COA
Test Method	HPLC
CAS No	1029877-94-8
Mf	C22h26fn5o6
MW	475
Brand	Biocar
Psa	171
Logp	1.23468
Transport Package	Negotiabie
Specification	99%
Trademark	D-Sung
Origin	Xi′an Shaanxi
Production Capacity	300kg/Month

Product Description

Blood Pressure Lowering Trelagliptin succinate powder Pharmaceutical Trelagliptin succinate Material Trelagliptin succinate Product Description

Product Datails

Product name	Trelagliptin succinate
CAS	1029877-94-8
Appearance	white powder
Assay	99%

Trelagliptin succinate (SYR-472) is a selective, long acting dipeptidyl peptidase-4 (DPP-4) inhibitor. An antidiabetic agent.Orally active DPP-4 inhibitor that produces clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes. SYR472 has a long duration of action and is well tolerated in clinical studies.

Application&Function

Trelagliptin succinate the world's first weekly oral DPP 4 inhibitors, used in type 2 diabetes, this product is a weekly dipeptide base peptidase IV (DPP - 4) inhibitors, through selective, sustained suppression DPP - 4, control blood sugar levels. DPP - 4 is an enzyme that can cause intestinal glucagon like peptide 1 (glp-1) promote and glucose dependence polypeptide (GIP) inactivation, and these two im down plays an important role in regulating blood sugar. Inhibiting dd-4 can increase blood glucose levels dependent on secretion, which can control blood glucose levels.Generally, adults take orally SYR-472 100mg once a week.
Specification